Following her two decades at biotechnology companies Amgen and Genentech, Slatter was elected in 2015 to the Bellevue City Council, and then appointed to the Legislature in 2017. She chairs the ...

Scientists have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop ...

At study sites in Seattle, San Diego, and Birmingham ... Research to Prevent Blindness; personal fees — Genentech, Sanofi, US FDA, Johnson and Johnson, Boehringer Ingelheim, Gyroscope; non-financial ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor.

Seattle Genetics is working with Genentech (who recently extended their ADC development deal with them), Millennium Pharmaceuticals, GlaxoSmithKline, Celldex Therapeutics, Progenics ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The long-term risk of distant recurrence for women with ...

In San Francisco, ICA Cristo Rey Academy students visit their Corporate Work Study partner, Genentech ... recently opened a Cristo Rey Jesuit Seattle High School this school year, while a new ...

Roche/Genentech, Sanofi, Seattle Genetics, Takeda, and Zymeworks; has done talks in a company's organised public event for AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, ...

She completed her postdoctoral training at Genentech under the mentorship of Dr. Ira Mellman ... non-invasively monitor immune cell interactions within tumors. Kate joined Seattle Children’s Research ...

Ms. Patel joins from Roche/Genentech, where she led the successful launch of Hemlibra ... Bristol Myers Squibb, Takeda Ventures, Seattle Children’s Research Institute and others to re-imagine medicine ...

Genentech, a member of the Roche (RHHBY), announced that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology, or ASH, annual meeting and ...